VAŠKŮ, Anna, Miroslav SOUČEK, Vladimír ZNOJIL, Lada RAMBOUSKOVÁ, Ivan ŘIHÁČEK, Karel CÍDL, Lenka STŘELCOVÁ and Jiří VÁCHA. Effect of one year antihypertensive therapy with angiotensin I converting enzyme (ACE) inhibitor on hemodynamic, hematological and biochemical parameters. Effects of I/D ACE and M235T and T174M angiotensinogen gene polymorphisms. Scripta medica. Brno: Lékařská fakulta Masarykovy univerzity, 1999, vol. 72, 2-3, p. 87-96. ISSN 1211-3395.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Effect of one year antihypertensive therapy with angiotensin I converting enzyme (ACE) inhibitor on hemodynamic, hematological and biochemical parameters. Effects of I/D ACE and M235T and T174M angiotensinogen gene polymorphisms
Authors VAŠKŮ, Anna (203 Czech Republic, guarantor), Miroslav SOUČEK (203 Czech Republic), Vladimír ZNOJIL (203 Czech Republic), Lada RAMBOUSKOVÁ (203 Czech Republic), Ivan ŘIHÁČEK (203 Czech Republic), Karel CÍDL (203 Czech Republic), Lenka STŘELCOVÁ (203 Czech Republic) and Jiří VÁCHA (203 Czech Republic).
Edition Scripta medica, Brno, Lékařská fakulta Masarykovy univerzity, 1999, 1211-3395.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/99:00001112
Organization unit Faculty of Medicine
Keywords in English quinapril; angiotensin-converting enzyme; angiotensinogen; ambulatory blood pressure monitoring
Tags Ambulatory blood pressure monitoring, angiotensin-converting enzyme, angiotensinogen, quinapril
Changed by Changed by: prof. MUDr. Anna Vašků, CSc., učo 122. Changed: 24/4/2003 11:04.
Abstract
The purpose of the study has been to evaluate the influence of one year angiotensin I-converting enzyme inhibitor (IACE) treatment on 24-h blood pressure (BP) and heart rate (HR) parameters, other hemodynamic (ECG, ECHO) parameters and hematological and biochemical tests in the genetic context of renin - angiotensin system gene polymorphisms. Eleven newly diagnosed essential hypertensives were treated with ACE inhibitor quinapril (Accupro, Gödecke, Berlin) for one year. All patients were genotyped for three polymorphisms - I/D of angiotensin I-converting enzyme and M235->T and T174->M of angiotensinogen genes, respectively. A decrease in the mean levels of systolic (p=0.001), mean arterial (p=0.002) and diastolic (p=0.003) blood pressures were found. No significant differences in ECG parameters nor differences in ECHO parameters became evident.However, a decrease in the red blood cell count (p=0.004) and an increase in the MCV of the RBCs (p=0.002) were observed. Differences in the blood glucose levels appeared to be associated with I/D ACE genotype (p=0.01).
Links
GA306/93/2192, research and development projectName: Polymorfismy genů pro angiotensinogen a angiotensin I konvertasu u esenciální hypertense.
Investor: Czech Science Foundation, Polymorphisms of Genes Coding for Angiotensinogen and Angiotensin I Convertase in Essential Hypertension
MSM 141100002, plan (intention)Name: Molekulární patofyziologie multigenních chorob
Investor: Ministry of Education, Youth and Sports of the CR, Molecular pathophysiology of multigene diseases
VS96097, research and development projectName: Molekulární patofyziologie vybraných "civilizačních", multigenně podmíněných chorob
Investor: Ministry of Education, Youth and Sports of the CR, Molecular pathophysiology of selected multigenic related to civilization diseases
PrintDisplayed: 9/9/2024 01:21